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Martin Reincke, MD; Bruno Allolio, MD; Wolfgang Saeger, MD; Jürgen Menzel, MD; Werner Winkelmann, MD 
The 'Incidentaloma' of the 
Pituitary Gland 
Is Neurosurgery Required? 
We describe a series of 18 patients with an intrasellar mass incidentally discov-
ered by computed tomography or magnetic resonance imaging. The average 
size of the mass was 13 mm, with a range from 5 to 25 mm. Initial ophthalmologic 
examination revealed bitemporal hemianopia in 2 patients. Results of routine 
endocrine testing showed partial hypopituitarism in 5 patients and growth hor-
mone hypersecretion without signs and symptoms of acromegaly in 1 patient. 
Four patients underwent neurosurgery. Histologically, one chondroid chordoma 
and three pituitary adenomas were found. In the remaining 14 patients treated 
conservatively, repeated computed tomography and magnetic resonance imag-
ing revealed no significant change in tumor size at the time of follow-up (median, 
22 months). Our results suggest that the "incidentaloma" of the pituitary gland is a 
benign condition that does not necessarily require neurosurgical intervention. 
{JAMA. 1990;263:2772-2776) 
I N 1936, Costello1 reported in his inves-
tigation entitled "Subclinical Adenomas 
of the Pituitary Gland" that in a series of 
1000 pituitary glands obtained from un-
selected autopsies pituitary adenomas 
occurred with the remarkable frequen-
cy of 22.5%. The tumors were unassoci-
ated with clinical signs or obvious hor-
monal abnormalities and remained 
undiagnosed during the subjects' life-
time. 
Costello's investigation has been 
cited in numerous publications. The 
From the Department of Medicine II, University of 
Cologne, Krankenhaus Merheim, West Germany (Drs 
Reincke and Allolio and Prof Dr Winkelmann); Depart-
ment of Pathology, Marienkrankenhaus Hamburg, 
West Germany (Prof Dr Saeger); Department of Neuro-
surgery, Krankenhaus Merheim, Cologne, West Ger-
many (Prof Dr Menzel). 
Reprint requests to Department of Medicine II, Kran-
kenhaus Merheim, Ostmerheimer Str 200, 5000 Köln 
91, West Germany (Dr Reincke). 
prevalence of subclinical pituitary ade-
nomas has been reexamined by many 
subsequent investigators and was found 
to vary from 4.8% to 27% in unselected 
autopsy subjects.2 In most cases, these 
adenomas were small and could only be 
detected by microscopy. Adenomas vis-
ible at the time of gross examination are 
detected less frequently. In the series of 
McComb et al,2 4 of 100 pituitary adeno-
mas incidentally discovered at the time 
of autopsy were detected already by 
gross examination. 
During the last two decades, the in-
troduction of radioimmunoassays, new 
radiological procedures, and microsur-
gical techniques have allowed early di-
agnosis and removal of small pituitary 
adenomas. However, even today, pitu-
itary adenomas are a common incidental 
finding at the time of autopsy.3,4 With 
wider application of computed tomogra-
phy (CT) and magnetic resonance imag-
ing (MRI), pituitary masses will be de-
tected incidentally during patients' 
lifetimes in increasing frequency. The 
diagnostic and therapeutic approach to 
patients with "incidentalomas" of the 
pituitary gland has not yet been estab-
lished. We, therefore, present herein 
the findings of 18 patients with a sub-
clinical pituitary mass incidentally dis-
covered by CT or MRI. 
PATIENTS AND METHODS 
Since 1980, we studied 27 patients (21 
female and 6 male) with an intrasellar 
mass incidentally discovered by CT or 
MRI (incidentaloma), which was de-
fined as follows: (1) the patient under-
went CT scanning (or MRI) for evalua-
tion of an unrelated disease, and (2) the 
patient did not complain of symptoms 
associated with a sellar mass (visual dis-
turbance, symptoms of hypopituita-
rism, or anterior pituitary hormone ex-
cess). Headache as an isolated symptom 
was considered to be nonspecific i f the 
life profile of it was chronic, recurrent, 
and unassociated with other important 
signs. Patients with headache of in-
creasing frequency and intensity were 
excluded. Patients with a primary para-
sellar or suprasellar mass or with the 
empty-sella syndrome were not in-
cluded in the study. 
Of the 27 patients with an incidenta-
loma of the pituitary gland, 9 cases were 
excluded from this study for the follow-
ing reasons: 6 patients were unavailable 
for follow-up, 1 patient had suspected 
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Table 1.—Clinical, Radiological, and Biochemical Characteristics of Four Patients With an 'Incidentaloma* of the Pituitary Gland That Required Neurosurgery* 
Maximum 
Patient/ 
Age, y/ 
Sex 
Complaint 
(Reason for CT) 
Tumor 
Diameter, 
mm 
Endocrine Function Visual Acuity 
Surgery Preoperative Postoperative Preoperative Postoperative Histology Immunostaining 
1/55/F Concussion 25 Transfrontal Hypopituitarism 
(LH, FSH) 
Hypopituitarism 
(C, TSH, LH, FSH) 
Bitemporal 
hemianopia 
Bitemporal 
hemianopia 
Chondroid 
chordoma 
2/64/M Cerebrovascular 
disease 
25 Transfrontal Hypopituitarism 
(LH, FSH) 
Hypopituitarism 
(C, TSH, LH, FSH) 
Bitemporal 
hemianopia 
Bitemporal 
hemianopia 
Chromophobic 
pituitary 
adenoma 
LHf, FSHt 
3/66/M Epilepsy 20 Transfrontal Normal Normal Normal Left 
hemianopia 
Oncocytic 
pituitary 
adenoma 
FSH}:, TSHt 
a-subunit§ 
4/35/M Cervical 
myelopathy 
17 Transsphenoidal GH hypersecretion Normal Normal Normal Acidophilic 
pituitary 
adenoma 
GHt, PRLt.TSHt 
*CT indicates computed tomography; LH (luteinizing hormone), FSH (follicle-stimulating hormone), C (corticotropin), and TSH (thyrotropin [thyroid-stimulating hormone]), 
hormone deficiencies in patients with hypopituitarism; GH, growth hormone; and PRL, prolactin. 
tLess than 10% of tumor cells stained. 
^Greater than 50% of tumor cells stained. 
§Ten percent to 50% of tumor cells stained. 
Table 2.—Clinical, Radiological, and Biochemical Data of 14 Patients With an 'Incidentaloma' of the Pituitary 
Gland Treated Conservatively* 
Patient/ 
Age, y/ 
Sex 
Complaint 
(Reason for CT) 
Maximum Tumor 
Diameter, mm 
First CT Last CT Endocrine Function 
Follow-up, 
mo 
5/65/F Concussion 22 25 Hypopituitarism (LH, FSH) 19 
b/bö/M cerebrovascular disease 20 20 Normal 20 
7/61/F Headache 16 15 Hypopituitarism (LH, FSH) 42 
8/59/M Cluster headache 14 20 Normal 20 
9/56/M Vertigo 14 14 Hypopituitarism (LH, FSH) 48 
10/32/F Psychiatric disorder 12 12 Normal 48 
11/27/F Headache 11 11 Normal 17 
12/15/F Epilepsy 9 9 Normal 29 
13/19/F Concussion 8 8 Normal 12 
14/22/F Syncope 8 4 Normal 14 
15/24/F Headache 8 8 Normal 17 
16/43/F Vertigo 8 8 Normal 24 
17/37/F Psychiatric disorder 5 5 Normal 20 
18/44/F Headache 5 9 Normal 96 
*CT indicates computed tomography; and LH (luteinizing hormone) and FSH (follicle-stimulating hormone), 
hormone deficiencies in patients with hypopituitarism. 
pituitary hyperplasia caused by prima-
ry hypothyroidism, and 2 patients had 
normal CT scans at the time of follow-
up, suggestive of artifacts that imitated 
a pituitary tumor in the initial scans. 
In the remaining 18 patients, com-
plete medical histories were recorded 
and physical examinations given initial-
ly and during follow-up. In addition, 
ophthalmologic examinations, including 
Goldman and computed perimetry, and 
routine pituitary function testing5 were 
performed. Assessment of the hormon-
al status included determination of 
baseline (and stimulated) hormone con-
centrations of plasma corticoptropin 
and serum Cortisol (corticoptropin-stim-
ulation test, overnight metyrapone 
test, and since 1986 corticotropin-re-
leasing hormone stimulation test), 
thyrotropin (thyroid-stimulating hor-
mone), triiodothyronine and thyroxine 
(thyrotropin-releasing hormone stimu-
lation test until 1988), prolactin (thyro-
tropin-releasing hormone stimulation 
test), luteinizing hormone and follicle-
stimulating hormone (gonadotropin-
releasing hormone stimulation 
test), testosterone, growth hormone 
(GH), somatomedin C. α-Subunit was 
not measured. Follow-up studies were 
done every 12 months and earlier in pa­
tients with large tumors. 
Plasma corticotropin levels were de­
termined by radioimmunoassay after 
extraction with microfine precipitated 
silica granules as described previously.6 
Cortisol, prolactin, thyrotropin, triio­
dothyronine and thyroxine, luteinizing 
hormone, follicle-stimulating hormone, 
GH, and somatomedin C levels were 
measured by radioimmunoassay or im-
munoradiometric assay with commer­
cially available reagents. 
Sections of tumor tissue were exam­
ined by light microscopy using conven­
tional and immunocytochemical tech­
niques described previously.7 Using the 
peroxidase-antiperoxidase method on 
paraffin-embedded sections, the follow­
ing commercial primary antibodies 
were tested: anticorticotropin, anti-
GH, antiprolactin, antithyrotropin, an­
ti-follicle-stimulating hormone, anti-
luteinizing hormone, anti-ct-subunit. 
High-resolution CT of the pituitary 
fossa in 2-mm sections was performed 
after intravenous administration of con­
trast material with second- and third-
generation scanning machines (Siemens 
Somatotom DR1 and DR2, Munich, 
Germany). Reformatting of multiple ax­
ial images was obtained in all patients; 
thin-section coronal scans were ob­
tained in 10 patients. 
Since 1987, in addition to CT, magnet­
ic resonance images in the coronal and 
sagittal views were obtained in eight 
patients at 1.0 Τ (Siemens Magentom 
LOT, Munich, Germany). Both T r and 
T2-weighted spin-echo pulse sequences 
were acquired before and after the ad­
ministration of gadolinium-diethylene-
triaminepentaacetic acid. 
RESULTS 
Clinical data of the patients are sum­
marized in Tables 1 and 2. In 17 pa­
tients, the pituitary mass was discov­
ered by CT and in patient 4 by MRI. 
Patients' ages ranged from 15 to 68 
years at the time of admission. The rea­
sons for CT scanning (or MRI) were 
headache of chronic pattern (n = 3), 
cluster headache (n=l ) , cerebrovascu­
lar disease (n = 2), psychiatric disorders 
(n = 2X vertigo (n=2), epilepsy (n=2), 
concussion (n = 2), and other causes 
(n = 4). Al l female patients except for 
the postmenopausal women had regular 
menses. None of the male patients com-
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Fig 1.—Initial coronal computed tomographic (CT) scan of patient 5 showing a large pituitary mass 
(maximum diameter, 22 mm) with suprasellar extension. The lesion was incidentally discovered by CT after 
head trauma and was completely asymptomatic. 
plained of loss of libido. 
On coronal CT scans, an intrasellar 
soft-tissue mass greater than 10 mm in 
maximum diameter was identified in 11 
patients (range, 11 to 25 mm) (Fig 1). 
Enhancement characteristics were var­
iable, with uniformly isodense lesions 
(5 patients), uniformly hypodense le­
sions (1 patient), and mixed-density le­
sions (5 patients) encountered relative 
to the adjacent cavernous sinus. Seven 
tumors extended into the suprasellar 
region. Magnetic resonance imaging 
was available in 6 of these patients. In 
2 patients (patients 1 and 2) with bitem­
poral visual field defects, the chiasm 
could not be discerned from the tumor 
by MRI. Displacement of the optic 
nerve was noted in patient 3, who had 
normal visual acuity. 
In seven patients, pituitary gland CT 
scans showed a small lesion (diameter, 
<10 mm) within the sella turcica. In five 
of these patients, the sella cavity was 
almost completely filled by homoge­
neously enhancing soft tissue, with a 
convex upper contour of the gland. The 
two other patients had a small, hypo-
dense lesion within the pituitary gland 
that was clearly distinguished from the 
normal enhancing parenchyma. Neither 
suprasellar nor parasellar extension nor 
sellar floor erosion was seen. 
Goldman or computed perimetry re­
vealed normal visual fields in 16 pa­
tients. Two patients showed a bitem­
poral visual field defect in the superior 
quadrant. The results of pituitary func­
tion testing was normal in 13 patients. 
Patients 1, 2, 5, and 7 had partial hypo­
pituitarism (secondary hypogonadism). 
Patient 3 showed elevated baseline lev­
els of GH and elevated somatomedin C 
concentrations without signs and symp­
toms of acromegaly. The GH concentra­
tions were not suppressed to less than 
2 μg/L during oral glucose tolerance 
testing and rose paradoxically after pro-
tirelin administration. 
In 4 patients, (Table 1) neurosurgery 
was performed for the following rea­
sons: visual field defects in patients 1 
and 2, displacement of the chiasm by the 
tumor demonstrated by MRI in patient 
3, and biochemical evidence of acromeg­
aly in patient 4. In all cases, complete 
removal of the tumor was achieved by 
the transfrontal (η = 3) and transsphe­
noidal (n = 1) route, respectively. Histo­
logically, a chondroid chordoma and 
three pituitary adenomas were found. 
Immunohistochemical studies showed 
strong GH immunoreactivity in patient 
4, follicle-stimulating hormone and thy­
rotropin immunoreactivity in patient 3, 
and luteinizing hormone and follicle-
stimulating hormone immunoreactivity 
in a few scattered cells in patient 2. 
Postoperatively, complete hypopituita­
rism that required replacement therapy 
developed in patients 1 and 2. Patient 4 
had normal baseline GH levels that 
were suppressible to less than 2 μg/L 
during the oral glucose tolerance test. 
Patient 3 had evidence of a left temporal 
visual field defect; visual field defects 
were unchanged in patient 2 and worse 
in patient 1. Follow-up studies were un­
eventful in all patients 12 to 24 months 
after surgery. 
During the follow-up period of the 14 
patients who were treated conserva­
tively (median, 22 months; range, 11 to 
96 months), no change in tumor size oc­
curred in 10 patients. Three patients 
had evidence of tumor growth (patients 
5, 8, and 18). Patient 14 showed tumor 
regression. Visual acuity remained in­
tact in all patients. The results of endo­
crine follow-up studies were unchanged 
in 13 patients. Patient 5 had a further 
decrease of serum gonadotropin levels, 
but thyrotropin and corticotropin secre­
tion remained intact. In 4 additional pa­
tients (patients 5, 8, 9, and 18), trans­
sphenoidal surgery was considered be­
cause of tumor growth or hypopituita­
rism. However, 3 patients refused to 
undergo neurosurgical intervention. 
The fourth patient was ineligible for 
surgery because of severe pulmonary 
disease. 
COMMENT 
In our report, we describe 18 patients 
with an incidentally discovered sellar 
mass. In 11 patients, the lesion was 
greater than 10 mm in diameter. How­
ever, only 2 of the patients had visual 
field defects, and only 5 patients (28%) 
had partial hypopituitarism. In 4 pa­
tients (22%), neurosurgery was per­
formed. Follow-up studies in the re­
maining 14 patients showed tumor 
growth in 3, whereas in the majority the 
lesions remained unchanged. To our 
knowledge, this is the first report of 
patients with an incidentaloma of the 
sellar region that provides complete 
clinical, biochemical, and follow-up 
data. 
We included patients who complained 
of chronic headache in our series of inci­
dentalomas of the pituitary gland. This 
symptom was considered to be nonspe­
cific and not to be caused by the tumor 
because patients with symptomatic pi­
tuitary lesions typically complain of 
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Fig 2.—Approach to the incidentally discovered noncystic mass. 
headache of recent onset or increasing 
frequency and intensity. In addition, 
Cohen et al8 reported in their large se­
ries of 100 patients with nonfunctioning 
pituitary adenomas that headache—the 
second most frequent symptom—was 
never observed as an isolated com­
plaint; it was always accompanied by 
visual symptoms. 
The pituitary region can now be easily 
evaluated by means of high-resolution 
CT9 and MRI. 1 0 By CT, it is best demon­
strated either directly on coronal scans 
or indirectly from data obtained in the 
axial plane and reformatted into coronal 
and sagittal images. The use of high-
resolution CT scans for the diagnosis of 
pituitary tumors is well established. In 
the case of tumors greater than 10 mm 
in diameter, the mass will be easily dem­
onstrated radiologically. However, in 
patients with suspected pituitary ade­
nomas smaller than 10 mm, CT has been 
found to be of less value in localizing the 
lesion.1112 
Magnetic resonance imaging has been 
shown to be superior to CT in the evalu­
ation of large pituitary tumors.1 0 1 3 I t is 
able to yield excellent anatomic presen­
tations of the tumor and its immediate 
surroundings. The suprasellar exten­
sion of the tumor and the impinging of 
the optic apparatus and the third ventri­
cle is more easily identified from MRI 
reconstructions than from CT images. 
In addition, MRI before and after ad­
ministration of gadolinium-diethylene-
triaminepentaacetic acid has been dem­
onstrated to be more effective in the 
detection of microadenomas of the pitu­
itary gland.14 Therefore, since 1987, 
MRI frequently has been used by us to 
confirm the presence of a pituitary tu­
mor and to define the relationship of the 
lesion to the surrounding anatomic 
structures. 
Asymptomatic pituitary adenomas 
are a common incidental finding at the 
time of autopsy.1"4 Most reported series 
showed an incidence of approximately 
20%.2 We believe that most of the inci-
dentalomas in our patients represent 
slowly growing pituitary microadeno­
mas and macroadenomas. No change in 
tumor size was noted in the majority of 
cases. This may be explained by the 
slow growth characteristics of pituitary 
adenoma cells, 
Patients with incidentalomas of the 
pituitary gland should be carefully mon­
itored for anterior pituitary hormone 
excess, although the majority of pa­
tients have nonfunctional pituitary tu­
mors. In the present study, only one 
patient with a GH-secreting adenoma 
had biochemical evidence of anterior pi­
tuitary hormone excess. No prolactin-
secreting pituitary tumor was detected. 
Immunohistochemistry revealed a gon­
adotroph cell adenoma in one patient 
whereas gonadotropin levels were nor­
mal or low in all patients. However, 
gonadotroph cell adenomas cannot real­
ly be excluded on this basis since serum 
α-subunit was not measured in our 
patients. 
Nevertheless, subclinical masses 
may be caused by abnormalities other 
than microadenomas or macroadeno­
mas. The differential diagnosis includes 
aneurysm, meningioma, and cranio­
pharyngioma,15 pituitary hyperpla­
sia,1 6 1 7 lymphoid adenohypophysitis,18,19 
pars intermedia cysts,3 metastasis to 
the pituitary gland,3 , 2 0 , 2 2 infarcts of the 
pituitary gland,23 and abscesses.3 
Aneurysm, parasellar meningioma, 
and craniopharyngioma sometimes 
mimic the CT characteristics of pitu­
itary tumors, especially the large pitu­
itary adenomas with suprasellar exten­
sion. However, generally they present 
a characteristic constellation of findings 
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on CT scans and MRI, which allows the 
differential diagnosis.15 
I t is well known that in patients with 
suspected microadenomas, artifacts 
may mimic low-density lesions on CT.3 
Earnest et al2 1 stated that a significant 
percentage of intrasellar low-density 
areas, visualized on reformatted images 
especially, represented artifacts associ­
ated with the bones of the skull base. 
We excluded two patients with normal 
CT scans at the time of follow-up from 
this study in whom probable artifacts 
initially imitated the findings of a true 
pituitary tumor. 
The therapeutic approach to patients 
with an incidentally discovered pitu­
itary mass has not yet been established. 
We believe that it is rational to observe 
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